109 related articles for article (PubMed ID: 5960301)
1. Cyclic methyldopa analogs as potential antihypertensive and antineoplastic agents.
Burckhalter JH; Schmied G
J Pharm Sci; 1966 Apr; 55(4):443-5. PubMed ID: 5960301
[No Abstract] [Full Text] [Related]
2. Screening data from the Caner Chemotherapy National Service Center Screening Laboratories. XXIX.
Leiter J; Abbott BJ; Schepartz SA
Cancer Res; 1965 Dec; 25(11 Pt 2):1779-2061. PubMed ID: 5856668
[No Abstract] [Full Text] [Related]
3. The antitumour activity of a series of benzothiophenes.
Hellmann K; Marshall PG; Stayt S
Biochem Pharmacol; 1967 Apr; 16(4):681-7. PubMed ID: 6033788
[No Abstract] [Full Text] [Related]
4. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
Mihich E; Nichol CA
Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
[No Abstract] [Full Text] [Related]
5. [Antineoplastic activity of complex compounds of platinum(IV)].
Presnov MA; Zheligovskaia NN; Babkov AV; Konovalova AL; Budanova NS
Dokl Akad Nauk SSSR; 1976 JUL-AUG; 229(1):226-9. PubMed ID: 954573
[No Abstract] [Full Text] [Related]
6. Potential carcinostatic agents. I. Derivatives and analogs of 1-(2-hydroxyethyl)-3-(4-tolyl)urea.
Nelson HG; Shelton FJ; Wetzel WH
J Med Chem; 1967 Jul; 10(4):735-6. PubMed ID: 6037073
[No Abstract] [Full Text] [Related]
7. Potential antitumor agents. Derivatives of 2-hydrazino-5-nitropyridine.
Prescott B; Caldes G
J Pharm Sci; 1970 Jan; 59(1):101-4. PubMed ID: 5411311
[No Abstract] [Full Text] [Related]
8. Imidazoles V. 5(or 4)-(3-alkyl-3-methyl-1-triazeno)imidazole-4(or 5)-carboxamides.
Shealy YF; Krauth CA; Clayton SJ; Shortnacy AT; Laster WR
J Pharm Sci; 1968 Sep; 57(9):1562-8. PubMed ID: 5674395
[No Abstract] [Full Text] [Related]
9. Cyclosporins: immunosuppressive agents with antitumor activity.
Kreis W; Soricelli A
Experientia; 1979 Nov; 35(11):1506-8. PubMed ID: 510504
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of potential antineoplastic agents. XIV. Some 2-substituted 2,3-dihydro-1h-perimidines.
Wasulko W; Noble AC; Popp FD
J Med Chem; 1966 Jul; 9(4):599-601. PubMed ID: 4165378
[No Abstract] [Full Text] [Related]
11. Antitumor activity of some acylhydrazines.
Rutner H; Lewin N; Woodbury EC; McBride RJ; Rao KV
Cancer Chemother Rep; 1974; 58(6):803-10. PubMed ID: 4447923
[No Abstract] [Full Text] [Related]
12. Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline.
Schuyler P; Popp FD; Noble AC; Alwani DW; Masters BR
J Med Chem; 1966 Sep; 9(5):704-7. PubMed ID: 6007964
[No Abstract] [Full Text] [Related]
13. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.
Leiter J; Abbott BJ; Schepartz SA
Can Res Suppl; 1964 Dec; ():1093-353. PubMed ID: 5878218
[No Abstract] [Full Text] [Related]
14. Potential central nervous system antitumor agents. Hydantoin derivatives.
Peng GW; Marquez VE; Driscoll JS
J Med Chem; 1975 Aug; 18(8):846-9. PubMed ID: 1159704
[TBL] [Abstract][Full Text] [Related]
15. Carcinostatic sulfonic acid esters of butyne- and butane-1,4-diols.
Earl RA; Harmon RE
J Med Chem; 1966 Sep; 9(5):776-8. PubMed ID: 5969056
[No Abstract] [Full Text] [Related]
16. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV.
Leiter J; Abbott BJ; Bourke AR; Schepartz SA; Wodinsky I
Cancer Res; 1963 Sep; 23(8 Pt 2):1483-729. PubMed ID: 5878214
[No Abstract] [Full Text] [Related]
17. Chemotherapeutic properities of anthramycin.
Grunberg E; Prince HN; Titsworth E; Beskid G; Tendler MD
Chemotherapy; 1966; 11(5):249-60. PubMed ID: 4959850
[No Abstract] [Full Text] [Related]
18. An approach to tumour biology in the light of prevention, cure and etiology.
Bose S; Chowdhury JR
Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
[No Abstract] [Full Text] [Related]
19. Potential carcinolytic agents. V. Enamine mustards.
Papanastassiou ZB; Bruni RJ; White E
J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064
[No Abstract] [Full Text] [Related]
20. Antitumoral activity of Panax ginseng extracts.
Lee KD; Huemer RP
Jpn J Pharmacol; 1971 Jun; 21(3):299-302. PubMed ID: 5314720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
